|
US5204252A
(en)
*
|
1989-02-08 |
1993-04-20 |
Henkel Research Corporation |
Candida tropicalis transformation system
|
|
ATE130049T1
(de)
*
|
1990-07-13 |
1995-11-15 |
Transkaryotic Therapies Inc |
Verfahren zum absuchen einer bibliothek.
|
|
WO1992013951A1
(en)
*
|
1991-02-04 |
1992-08-20 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Production of human serum albumin in methylotrophic yeast cells
|
|
US5866543A
(en)
*
|
1995-06-05 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5945275A
(en)
*
|
1994-10-18 |
1999-08-31 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
ES2276396T3
(es)
|
1994-10-18 |
2007-06-16 |
Dendreon Corporation |
Proteinas anticoagulantes e inhibidores de la serina proteasa extraidos de nematodos.
|
|
US5872098A
(en)
*
|
1995-06-05 |
1999-02-16 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
US5866542A
(en)
*
|
1994-10-18 |
1999-02-02 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
CA2202351A1
(en)
*
|
1994-10-18 |
1996-04-25 |
George Phillip Vlasuk |
Nematode-extracted serine protease inhibitors and anticoagulant proteins
|
|
US5863894A
(en)
*
|
1995-06-05 |
1999-01-26 |
Corvas International, Inc. |
Nematode-extracted anticoagulant protein
|
|
MX9605082A
(es)
|
1996-10-24 |
1998-04-30 |
Univ Autonoma De Nuevo Leon |
Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano.
|
|
WO2000071716A2
(en)
*
|
1999-05-20 |
2000-11-30 |
Scios Inc. |
Vascular endothelial growth factor dimers
|
|
US6475796B1
(en)
|
1999-05-20 |
2002-11-05 |
Scios, Inc. |
Vascular endothelial growth factor variants
|
|
US6261820B1
(en)
*
|
1999-10-01 |
2001-07-17 |
Amgen Inc. |
Fibronolytically active polypeptide
|
|
US6440414B1
(en)
*
|
1999-10-01 |
2002-08-27 |
Amgen Inc. |
Pharmaceutical compositions of fibrinolytic agent
|
|
US7033776B2
(en)
*
|
1999-12-17 |
2006-04-25 |
Amgen Inc. |
Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
|
|
WO2001077366A1
(en)
*
|
2000-04-10 |
2001-10-18 |
Cubist Pharmaceuticals, Inc. |
Positive selection method, compounds, host cells and uses thereof
|
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
|
AU2001276842B2
(en)
|
2000-06-28 |
2007-04-26 |
Glycofi, Inc. |
Methods for producing modified glycoproteins
|
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
|
US7598055B2
(en)
*
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
WO2002000856A2
(en)
|
2000-06-30 |
2002-01-03 |
Flanders Interuniversity Institute For Biotechnology (Vib) |
Protein glycosylation modification in pichia pastoris
|
|
IL161988A0
(en)
|
2001-11-16 |
2005-11-20 |
Corporation Idec Pharmaceutica |
Polycistronic expression of antibodies
|
|
US7252933B2
(en)
|
2002-06-26 |
2007-08-07 |
Flanders Interuniversity Institute For Biotechnology |
Protein glycosylation modification in methylotrophic yeast
|
|
DE60335602D1
(de)
*
|
2002-12-18 |
2011-02-17 |
Roche Diagnostics Gmbh |
Rekombinante Desoxyribonuclease I aus Rinder-Pankreas mit hoher spezifischer Aktivität
|
|
ATE387494T1
(de)
*
|
2002-12-20 |
2008-03-15 |
Hoffmann La Roche |
Hitzelabile desoxyribonuklease i-varianten
|
|
US7332299B2
(en)
*
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
|
EP1460425A1
(en)
*
|
2003-03-17 |
2004-09-22 |
Boehringer Mannheim Gmbh |
Deglycosylated enzymes for conjugates
|
|
CA2486195C
(en)
*
|
2003-12-05 |
2012-03-06 |
Stephan Glaser |
Recombinantly expressed carboxypeptidase b and purification thereof
|
|
US7588745B2
(en)
*
|
2004-04-13 |
2009-09-15 |
Si Options, Llc |
Silicon-containing products
|
|
PT1926749E
(pt)
*
|
2005-09-14 |
2011-09-29 |
Sanofi Aventis Deutschland |
Clivagem de precursores de insulinas por uma variante de tripsina
|
|
BRPI0711898A2
(pt)
*
|
2006-05-19 |
2011-12-27 |
Glycofi Inc |
composiÇço de proteÍna da eritropoietina substancialmente homogÊnea, composiÇço farmacÊutica, e, mÉtodos de aumentar hematàcrito em um mamÍfero, e de produzir uma composiÇço de eritropoietina
|
|
BRPI0816837B1
(pt)
|
2007-09-28 |
2022-10-18 |
Portola Pharmaceuticals, Inc |
Composições farmacêuticas, polipeptídeo isolado de duas cadeias e uso de uma composição farmacêutica
|
|
US8067339B2
(en)
|
2008-07-09 |
2011-11-29 |
Merck Sharp & Dohme Corp. |
Surface display of whole antibodies in eukaryotes
|
|
CN102177247A
(zh)
|
2008-08-12 |
2011-09-07 |
格利科菲公司 |
用于蛋白生产: ca2+ atp酶过表达的改良的载体和酵母菌株
|
|
US8278418B2
(en)
|
2008-09-26 |
2012-10-02 |
Ambrx, Inc. |
Modified animal erythropoietin polypeptides and their uses
|
|
PT3604510T
(pt)
|
2009-03-30 |
2025-06-24 |
Alexion Pharma Inc |
Antídotos para inibidores do fator xa e métodos de utilização dos mesmos
|
|
PT2453910T
(pt)
|
2009-07-15 |
2016-12-07 |
Portola Pharm Inc |
Formulação de dose unitária de antídoto contra inibidores de fator xa para uso na prevenção de sangramento
|
|
MX2012004381A
(es)
|
2009-10-16 |
2012-06-01 |
Merck Sharp & Dohme |
Metodo para producir proteinas en pichia pastoris que carecen de actividad de entrelazamiento detectable con anticuerpos contra antigenos de la celula hospedera.
|
|
BR112012009886A2
(pt)
|
2009-10-30 |
2015-09-15 |
Merck Sharp & Dohme |
célula, e, método para produzir uma proteína recombinante em uma célula hospedeira
|
|
BR112012020882A2
(pt)
|
2010-02-24 |
2015-11-03 |
Merck Sharp & Dohme |
métodos para produzir uma glicoproteína heteróloga e para produzir uma composição de glicoproteína, célula hospedeira, composição de glicoproteína, e, uso da pichia pastoris recombinante.
|
|
PT2710114T
(pt)
|
2011-05-20 |
2021-12-09 |
H Lundbeck As |
Produção com pureza elevada de proteínas de múltiplas subunidades, como sejam anticorpos, em microrganismos transformados tais como pichia pastoris
|
|
EP2744903B1
(en)
|
2011-08-19 |
2018-10-10 |
AlderBio Holdings LLC |
Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as a antibodies in transformed microbes such as pichia pastoris
|
|
KR20140131957A
(ko)
|
2012-02-14 |
2014-11-14 |
포톨라 파마슈티컬스, 인코포레이티드 |
Xa 인자 억제제에 대한 재조합 해독제를 제조하는 방법
|
|
JP6735561B2
(ja)
|
2012-12-03 |
2020-08-05 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
Ｏ−グリコシル化カルボキシ末端部分（ｃｔｐ）ペプチド系のインスリンおよびインスリン類似体
|
|
WO2014138188A1
(en)
|
2013-03-07 |
2014-09-12 |
The General Hospital Corporation |
Human ctla4 mutants and use thereof
|
|
ES3057435T3
(en)
|
2013-03-15 |
2026-03-02 |
H Lundbeck As |
Temperature shift for high yield expression of polypeptides in yeast and other transformed cells
|
|
ES2834113T3
(es)
|
2013-03-15 |
2021-06-16 |
H Lundbeck As |
Purificación de anticuerpos y monitorización de la pureza
|
|
CA2917912C
(en)
*
|
2013-07-24 |
2019-09-17 |
Streck, Inc. |
Compositions and methods for stabilizing circulating tumor cells
|
|
US11168351B2
(en)
|
2015-03-05 |
2021-11-09 |
Streck, Inc. |
Stabilization of nucleic acids in urine
|
|
WO2017011275A1
(en)
|
2015-07-10 |
2017-01-19 |
Nersissian Aram M |
Factor viii protein compositions and methods of treating hemophilia a
|
|
EP3359666B1
(en)
|
2015-10-09 |
2025-02-19 |
Genzyme Corporation |
Early post-transfection isolation of cells (epic) for biologics production
|
|
US20170145475A1
(en)
|
2015-11-20 |
2017-05-25 |
Streck, Inc. |
Single spin process for blood plasma separation and plasma composition including preservative
|
|
EP3491381B1
(en)
|
2016-07-29 |
2025-09-24 |
Streck LLC |
Suspension composition for hematology analysis control
|
|
MX2019004013A
(es)
|
2016-10-07 |
2019-08-14 |
Genzyme Corp |
Aislamiento temprano de celulas despues de la transfeccion (epic) para la produccion de productos biologicos.
|
|
HUE068517T2
(hu)
|
2017-10-19 |
2024-12-28 |
Streck Llc |
A hemolízis és a véralvadás szabályozására, valamint az extracelluláris vezikulák stabilizálására szolgáló készítmények
|
|
EP3505181B1
(en)
|
2017-12-28 |
2021-07-07 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
Preparation of enzyme replacement therapy for mucopolysaccharidosis iiid
|
|
EP3927731A4
(en)
|
2019-02-19 |
2022-12-28 |
The Regents of the University of Colorado, a body corporate |
BISPECIFIC IMMUNOTOXINS FOR TARGETING HUMAN CD25S-CCR4+ TUMORS AND REGULATORY T-CELLS
|
|
PT4010379T
(pt)
|
2019-08-08 |
2025-06-30 |
Alexion Pharma Inc |
Composições e métodos de preparação do fator xa e derivados
|
|
NL2031833B1
(en)
|
2022-05-11 |
2023-11-17 |
Univ Leiden |
Immunotherapeutic compositions and adjuvants
|
|
WO2024032891A1
(en)
|
2022-08-11 |
2024-02-15 |
Vib Vzw |
Glyco-engineered yeast for therapeutic protein production
|
|
WO2025196308A1
(en)
|
2024-03-22 |
2025-09-25 |
Vib Vzw |
Means and methods for displaying fc-containing proteins on cells and selection thereof
|